The Lymphoma Hub are pleased to present a series of expert interviews from the 2nd European CAR T Cell Meeting in Sitges, ES. In this video, Claudia Rössig, University of Münster, Münster, DE, talks about the implementation of CAR T in the real-world.
Claudia Rössig explains that she expected CAR T therapy to be available to patients who need it, and that expectation was met to a certain extent. She also discusses its possible role in earlier lines of therapies and states that she expects that CAR T therapy is going to be implemented in early line of therapy in the next five years.